MustGrow publishes investor presentation on mustard-derived biological crop protection products
Reuters2026/08/12 16:09- MustGrow outlined commercialization plans for mustard-derived biological crop inputs spanning biofertility, biocontrol, postharvest, and animal health applications.
- TerraSante biofertility targets U.S. high-value crops; product registered in key states; 2025 supply sold out with about 1,000 acres applied.
- TerraMG biocontrol registrations targeted for 2026/2027 in Canada and the U.S.; positioned as an organic alternative to soil fumigants.
- Exclusive Bayer license covers EMEA biocontrol registration; MustGrow expects upfront and milestone payments, then royalties after registration.
- Presentation cited 70,441,359 shares outstanding; fully diluted 91,914,368; market cap CAD 30 million; cash CAD 419,577 at March 31, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
UBS lowers Ciena target price to $394
EUR/USD Price Forecast: Holds key 100-day SMA at start of the US CPI week
Malaysia Govt Spending Plan Could Help 99 Speed Mart Retail -- Market Talk
Paying the price for supporting the yen? Japan's foreign reserves fell by $87.8 billions in August, possibly due to selling US Treasuries for funding.
Japanese authorities may have used part of their foreign exchange reserves, including foreign securities such as U.S. Treasury bonds, over the past month to fund record-sized foreign exchange intervention operations.
Crypto prices
More
